pLKO5d.SFFV.dCas9-KRAB.P2A.BSD Citations (2)

Originally described in: The non-coding RNA landscape of human hematopoiesis and leukemia.
Schwarzer A, Emmrich S, Schmidt F, Beck D, Ng M, Reimer C, Adams FF, Grasedieck S, Witte D, Kabler S, Wong JWH, Shah A, Huang Y, Jammal R, Maroz A, Jongen-Lavrencic M, Schambach A, Kuchenbauer F, Pimanda JE, Reinhardt D, Heckl D, Klusmann JH Nat Commun. 2017 Aug 9;8(1):218. doi: 10.1038/s41467-017-00212-4. PubMed Journal

---

Articles Citing pLKO5d.SFFV.dCas9-KRAB.P2A.BSD

Articles
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. Anderson GSF, Ballester-Beltran J, Giotopoulos G, Guerrero JA, Surget S, Williamson JC, So T, Bloxham D, Aubareda A, Asby R, Walker I, Jenkinson L, Soilleux EJ, Roy JP, Teodosio A, Ficken C, Officer-Jones L, Nasser S, Skerget S, Keats JJ, Greaves P, Tai YT, Anderson KC, MacFarlane M, Thaventhiran JE, Huntly BJP, Lehner PJ, Chapman MA. Blood. 2022 Apr 21;139(16):2471-2482. doi: 10.1182/blood.2021015161. PubMed
The Bovine Seminal Plasma Protein PDC-109 Possesses Pan-Antiviral Activity. Sperber HS, Sutter K, Muller K, Muller P, Schwarzer R. Viruses. 2022 Sep 13;14(9):2031. doi: 10.3390/v14092031. PubMed

If you have published an article using this material, please email us at to have your article added to this page.